Small trials utilizing widely available antihistamine blockers for H1R and H2R in IBD fail to demonstrate clear efficacy, suggesting that they may not be critical in IBD pathogenesis
A lot of people want to use it
Others spend several days genuinely uncomfortable
Today's episode, I think, covers a lot of areas of the psychology around this, but we've definitely worked on people, with people on drugs like terzepatide, helping them build the foundation they need to eventually transition off of them while maintaining the results
doi: Rayamajhi S, Shrestha R, Sunuwar N, et al
It is important to note that individual experiences vary considerably, and not all patients experience these sensations